Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pathetic disinterest in the stock. One day away from the Markman hearing

which WILL ultimately determine this Federal District Court's view on the 336, and yesterday there was only $6,000 total worth of new speculation in ownership of company stock ????

I trust everyone is aware of our initial success with the previous Rulings on the other patents, but explicit statements the Court made regarding considerations for the 336 make this Ruling outcome special. It appears to me that this is a lynchpin Ruling for infringments impacting all our Patents, regardless of the venue.

Share
New Message
Please login to post a reply